Gut microbiota in patients after surgical treatment for colorectal cancerOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study used 16S rRNA gene sequencing to characterize the gut microbiota across the colorectal cancer disease course. It compared microbial diversity, overall community composition, and taxonomic abundance among colorectal adenoma patients, colorectal cancer (CRC) patients, and CRC patients after surgical treatment. The study also examined how postoperative gut microbiota related to colonoscopy findings and to CRC prognosis.
Who was studied?
The comparison groups were colorectal adenoma patients, CRC patients, CRC postoperative (post-surgical) patients, and healthy controls. Postoperative patients were further divided into those with newly developed adenoma on colonoscopy versus those with a clean intestine. The abstract does not give specific sample sizes, so exact cohort numbers cannot be stated.
What were the most important findings?
Gut microbiota composition shifted progressively along the adenoma-carcinoma sequence, with marked changes occurring before or during CRC development. The gut microbiota of postoperative patients differed significantly from that of CRC patients, showing that surgery does not restore a healthy-control-like microbial profile. Among postoperative patients, those who developed new adenomas had a microbiota more similar to carcinoma patients than to healthy controls, and differences between postoperative subgroups corresponded to CRC prognosis.
What are the greatest implications of this study?
Persistent microbiota alterations after CRC surgery suggest the gut microbiome could serve as a monitoring tool for recurrence risk and prognosis in postoperative patients. A microbiota signature resembling carcinoma in patients with new adenomas points to the gut microbiome as a potential early warning marker distinct from clean-intestine recovery. This abstract does not mention Desulfovibrio, sulfate-reducing bacteria, hydrogen sulfide, or sulfur metabolism, so no sulfide-related angle applies here.